Blog

Welcome to our blog! Explore educational content ranging from innovative treatments to insightful medical knowledge, curated by Dr. Rezaian, a specialist in Rheumatology and Internal Medicine.

Breathing Uneasy: High Rates of Hidden Lung Issues in Newly Diagnosed Arthritis

Breathing Uneasy: High Rates of Hidden Lung Issues in Newly Diagnosed Arthritis

Background and Purpose: Pulmonary issues are common yet often overlooked in people with rheumatic diseases like rheumatoid arthritis (RA), psoriatic arthritis (PsA), and peripheral spondyloarthritis (pSpA). These lung problems can lead to severe health consequences if...

read more

Hydroxychloroquine: A Shield Against Fatty Liver Disease in Rheumatoid Arthritis Patients

Hydroxychloroquine: A Shield Against Fatty Liver Disease in Rheumatoid Arthritis Patients

Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects the joints and can lead to various other health issues. Previous research has indicated a high prevalence of non-alcoholic fatty liver disease (NAFLD) in RA patients. There’s a...

read more

New Study Links Biologics to Lower Heart Disease Risk in RA

New Study Links Biologics to Lower Heart Disease Risk in RA

Background: Rheumatoid arthritis (RA) patients often face higher cardiovascular risks due to chronic inflammation. Biologic disease-modifying antirheumatic drugs (biologic drugs) help control this inflammation, especially in those who don’t respond well to...

read more

Enhancing Arthritis Prediction: The Promise of anti-CCP3 Testing

Enhancing Arthritis Prediction: The Promise of anti-CCP3 Testing

Background: The study aimed to determine if testing for anti-CCP3 antibodies in patients who are negative for anti-CCP2 antibodies but have musculoskeletal symptoms could better predict the progression to inflammatory arthritis (IA) or rheumatoid arthritis (RA)....

read more

TNFi Resistance in Juvenile Arthritis: Identifying the High-Risk Factors

TNFi Resistance in Juvenile Arthritis: Identifying the High-Risk Factors

This study investigated why some children with juvenile spondyloarthritis (JSpA) do not respond to TNF inhibitors (TNFi), a common treatment. Researchers analyzed data from patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA)...

read more

Gender-Specific Insights into Axial Juvenile Spondyloarthritis: What the Data Reveals

Gender-Specific Insights into Axial Juvenile Spondyloarthritis: What the Data Reveals

Background/Purpose: The study explores the differences between males and females with axial juvenile spondyloarthritis (axJSpA), a type of juvenile inflammatory arthritis. The goal was to understand if there are distinct clinical and imaging features based on sex....

read more

Exploring High-Dose Etanercept for Juvenile Arthritis: Does More Mean Better?

Exploring High-Dose Etanercept for Juvenile Arthritis: Does More Mean Better?

Background: Juvenile idiopathic arthritis (JIA) is a condition in children causing joint inflammation. Etanercept is a common medication for JIA, but the best dose for effectiveness is unclear. This study looks at whether increasing the dose of etanercept helps...

read more

Ruxolitinib Delivers Life-Saving Results for Juvenile Arthritis Patients

Ruxolitinib Delivers Life-Saving Results for Juvenile Arthritis Patients

Background: Systemic juvenile idiopathic arthritis (sJIA) is a severe form of arthritis in children that can lead to serious complications like macrophage activation syndrome (MAS) and lung disease. Even with current treatments like steroids and IL-1 inhibitors, some...

read more

Long-Term Pain Relief: How a Plant-Based Diet Transforms Osteoarthritis Treatment

Long-Term Pain Relief: How a Plant-Based Diet Transforms Osteoarthritis Treatment

Background: The “Plants for Joints” (PFJ) program is a 16-week lifestyle intervention aimed at people with osteoarthritis (OA) of the hip or knee and metabolic syndrome. The program includes a whole-food, plant-based diet, physical activity, and stress management....

read more

Breaking New Ground: Safe and Effective Gene Therapy for Knee Pain

Breaking New Ground: Safe and Effective Gene Therapy for Knee Pain

Background: This study aimed to evaluate the safety and effectiveness of XT-150, a new gene therapy, for treating moderate to severe pain caused by osteoarthritis (OA) of the knee. XT-150 is designed to produce a special version of the anti-inflammatory protein...

read more

Meet The Author

M M Rezaian, MD

M M Rezaian, MD

Rheumatology

Dr. Rezaian, who has dedicated over thirty years to the practice of Rheumatology, focuses on the utilization of biologic therapies for treating rheumatic diseases, the study of Spondyloarthropathy, and the innovative field of Telemedicine. He is connected with the WVU Berkeley Medical Center in Martinsburg, West Virginia.